|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UNDER CONSTRUCTION | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Monday, November 06, 2006
AWARD: Scott Johnson, President and Founder of the Myelin Repair Foundation
Scott Johnson, President and Founder of the Myelin Repair Foundation (MRF), has been recognized by Scientific American magazine as one of 50 research, policy and business leaders worldwide who have played a critical role in driving key science and technology trends over the last year. Johnson was selected for his policy leadership in encouraging innovation in multiple sclerosis research. Johnson founded the Myelin Repair Foundation with one goal in mind: to identify myelin repair drug targets within five years that would lead to treatments for multiple sclerosis. To that end, he developed an Accelerated Research Collaboration™ model to more rapidly discover, develop and deliver myelin repair treatments to those suffering from multiple sclerosis. In two years, MRF scientists participating in the collaboration have identified nine new myelin repair drug targets and 10 new research tools, that have broader application to all neurological research. More than 40 other disease research organizations have expressed interest in MRF's Accelerated Research Collaboration model and how it is revolutionizing medical research. "I share this honor with MORE |